MARC Record from marc_columbia

LEADER: 04123cam a2200505 i 4500
001 11690862
005 20160223151145.0
008 151020s20152015paua b 001 0 eng
010 $a 2015458479
016 7 $a101664368$2DNLM
019 $a898051880$a898161823
020 $a9781608311767 (hbk.)
020 $a1608311767 (hbk.)
029 1 $aNLM$b101664368
029 1 $aAU@$b000054967528
035 $a(OCoLC)ocn910230327
035 $a(OCoLC)910230327$z(OCoLC)898051880$z(OCoLC)898161823
035 $a(NNC)11690862
040 $aDLC$beng$erda$cDLC$dCDX$dYDXCP$dBTCTA$dBDX$dVAM$dKOS$dVET$dNLM$dOCLCF$dCUS
042 $apcc
050 00 $aRC382$b.P257 2015
060 00 $aWL 359$bP248154 2015
082 00 $a616.8/33$223
245 00 $aParkinson's disease & movement disorders /$c[edited by] Joseph Jankovic, Eduardo Tolosa.
250 $aSixth edition.
264 1 $aPhiladelphia :$bWolters Kluwer,$c[2015]
264 4 $c©2015
300 $axii, 576 pages :$billustrations (some color) ;$c29 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
500 $aPrevious edition: ©2007.
500 $a"Includes interactive eBook with video atlas"--Cover.
504 $aIncludes bibliographical references and index.
505 00 $aFunctional organization of the basal ganglia -- Neurophysiologic testing of motor control and movement disorders -- Neurobehavioral disorders associated with basal ganglia lesions -- Mechanisms and prevention of cell death -- Epidemiology of Parkinson's disease -- Nonmotor symptoms in Parkinson's disease -- Etiology and pathogenesis of Parkinson's disease -- Genetics of Parkinson's disease -- Disease-modifying strategies in Parkinson's disease -- Pharmacologic management of Parkinson's disease -- Experimental therapeutics of Parkinson's disease -- Dementia associated with Parkinson's disease: features and management -- Neuropsychiatric aspects of Parkinson's disease -- Progressive supranuclear palsy -- Multiple system atrophy -- Corticobasal degeneration -- Extrapyramidal syndromes in frontotemporal dementia -- Secondary Parkinsonsim -- Huntington's disease -- Sydenham chorea and other choreas -- Ballism -- Stereotypies -- Neurodegeneration with brain iron accumulation -- Neurologic aspects of Wilson's disease: clinical manifestations and treatment considerations -- Neuropathology of Parkinsonian disorders -- Mitochondria in movement disorders -- Essential tremor and other tremors -- Dystonic disorders -- Treatment of dystonia -- Tics and tourette syndrome -- Myoclonus and exaggerated startle syndrome -- Paraneoplastic and immunologically mediated movement disorders -- Drug-induced movement disorders -- Restless legs syndrome and akathisia -- Hereditary ataxias -- Disorders of gait -- Paroxysmal dyskinesias -- Catatonia -- Movement disorders in children -- Rigidity and spasticity -- Sleep and fatigue in Parkinson's disease -- Movement disorders in systemic disease -- Functional (psychogenic) movement disorders -- Neuroacanthocytosis -- Functional neuroimaging in movement disorders -- Botulinum toxin in movement disorders -- Surgery for Parkinson's disease -- Surgery for hyperkinetic movement disorders -- Cell-based therapy for Parkinson's disease -- Trophic factor and gene therapies for Parkinson's disease -- Nonpharmacologic multidisciplinary approach to the treatment of Parkinson's disease -- Peripherally induced movement disorders -- Clinical rating scales in movement disorders.
520 8 $aTop experts from all over the world have been brought together by the editors, to give a world of expertise on this important subject, with a strong emphasis on therapy and management.
650 0 $aParkinson's disease.
650 0 $aMovement disorders.
650 12 $aParkinson Disease.
650 22 $aMovement Disorders.
650 7 $aMovement disorders.$2fast$0(OCoLC)fst01028493
650 7 $aParkinson's disease.$2fast$0(OCoLC)fst01053693
700 1 $aJankovic, Joseph,$eeditor.
700 1 $aTolosa, Eduardo,$eeditor.
852 00 $boff,hsl$hRC382$i.P257 2015